Article
Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes
29 Apr 2025
Abstract excerpt
Diagnostic delays in patients with brain cancer are common and can impact patient outcome. Development of a blood-based assay for detection of brain cancers could accelerate brain cancer diagnosis. In this study, we analyzed genome-wide cell-free (cfDNA) fragmentomes, including fragmentation profiles and repeat landscapes, from the plasma of individuals with (n = 148) or without (n = 357) brain cancer. Machine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
